Europe is in urgent need! A new wave of monkeypox outbreak is coming! The most aggressive concept stocks have suddenly surged by 110%! According to the latest news, the European Center for Disease Control and Prevention has raised the risk level of sporadic monkeypox cases in the European Union from "low" to "medium", and the overall risk of monkeypox infection in the EU from "very low" to "low". European countries are also required to remain highly vigilant towards travelers from areas affected by the epidemic. Margaret Harris, spokesperson for the World Health Organization, warned that more monkeypox cases are expected to occur soon outside of Africa, which is also a result of strengthened testing. With the new round of monkeypox epidemic attracting market attention, the stock prices of pharmaceutical manufacturers and related companies that produce and develop monkeypox vaccines have skyrocketed across the board. The most aggressive performer is undoubtedly GeoVax Labs, a monkeypox concept stock in the US stock market, whose stock price surged 110% last Friday.